Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 819 of 1,261

  1. US 8710064

    2-aryl-4-quinazolinones and their pharmaceutical compositions

    China Medical University · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  2. US 8710075

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  3. US 8710031

    Compounds for nonsense suppression and methods for their use

    PTC THERAPEUTICS, INC. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  4. US 8710081

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Panmira Pharmaceuticals, LLC · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  5. US 8710030

    Phosphonate compounds

    The Regents of the University of California · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  6. US 8710026

    MiR 204, miR 211, their anti-miRs, and therapeutic uses of same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  7. US 8710185

    Bacterial superantigen vaccines

    The United States of America as represented by the Secretary of the Army · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  8. US 8709784

    Use of Lactobacillus for liver protection

    China Medical University · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  9. US 8710017

    Human and mouse targeting peptides identified by phage display

    The Board of Regents of the University of Texas System · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  10. US 8709433

    Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  11. US 8703987

    Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile)copper(I) tetrafluoroborate

    Draximage Limited · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  12. US 8703192

    Dosage form containing pantoprazole as active ingredient

    TAKEDA GMBH · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  13. US 8703150

    Methods of using Bacillus anthracis protective antigen sequences for vaccination

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  14. US 8703098

    Labelled adrenomedullin derivatives and their use for imaging and therapy

    INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  15. US 8703758

    Bicyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  16. US 8703840

    Dental adhesive material kit

    KURARAY NORITAKE DENTAL INC. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  17. US 8703735

    Antisense antiviral compounds and methods for treating a filovirus infection

    Sarepta Therapeutics, Inc. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  18. US 8703730

    Complement antagonists and uses thereof

    REGENESANCE B.V. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  19. US 8703920

    Fully human antibodies against N-cadherin

    The Regents of the University of California · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  20. US 8703921

    Compositions and methods for delivering inhibitory oligonucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  21. US 8703938

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  22. US 8703096

    Beta-amyloid PET imaging agents

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  23. US 8703115

    Methods for preparing conjugates

    Nektar Therapeutics · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  24. US 8703140

    Inhibition of factor B, the alternative complement pathway and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.